Weed (BUDZ) Non Operating Income (2010 - 2025)
Weed (BUDZ) posted quarterly Non Operating Income of -$5718.0 for Q1 2025, down 80.78% year-over-year from -$29746.8 in Q1 2024, and down 80.78% quarter-over-quarter from -$3163.0 in Q1 2024.
Weed (BUDZ) Non Operating Income (2010 - 2025) Analysis & Trends
Weed's Non Operating Income history runs 5 years deep, the most recent figure standing at -$5718.0 for Q1 2025.
- In Q1 2025, Non Operating Income fell 80.78% year-over-year to -$5718.0; the TTM figure through Mar 2025 stood at -$3645.0 (down 406.05% YoY), while the FY2024 annual figure was -$50325.0, down 106.8% from the prior year.
- Non Operating Income for Q1 2025 stood at -$5718.0, down from -$3163.0 in the prior quarter.
- The five-year high for Non Operating Income was -$3163.0 in Q1 2024, with the low at -$5718.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -5,718.00 |
| Mar 31, 2024 | -3,163.00 |
| Mar 31, 2012 | -882.00 |
| Dec 31, 2011 | 6,118.00 |
| Sep 30, 2011 | -882.00 |
| Jun 30, 2011 | -873.00 |
| Mar 31, 2011 | -863.00 |
| Dec 31, 2010 | 6,118.00 |
| Sep 30, 2010 | -882.00 |